Pytela; Robert

Patent Applications and Registrations

Patent applications and USPTO patent grants for Pytela; Robert.The latest application filed is for "anti-ox40 antibodies and diagnostic uses thereof".

Company Profile

1.13.17

Pytela; Robert - San Francisco CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Anti-OX40 antibodies and diagnostic uses thereof Grant 10,975,157 - Zhu , et al. April 13, 2	2021-04-13
Fusion partner for production of monoclonal rabbit antibodies Grant 10,377,814 - Pytela , et al. A	2019-08-13
Anti-ox40 Antibodies And Diagnostic Uses Thereof App 20180208666 - Zhu; Yifei ; et al.	2018-07-26
Fusion Partner for Production of Monoclonal Rabbit Antibodies App 20160207982 - Pytela; Robert ; et al.	2016-07-21
Fusion partner for production of monoclonal rabbit antibodies Grant 9,328,333 - Pytela , et al. May 3, 2	2016-05-03
Fusion Partner for Production of Monoclonal Rabbit Antibodies App 20140349393 - PYTELA; ROBERT ; et al.	2014-11-27
Fusion Partner for Production of Monoclonal Rabbit Antibodies App 20140004566 - Pytela; Robert ; et al.	2014-01-02
Fusion partner for production of monoclonal rabbit antibodies Grant 8,367,408 - Pytela , et al. February 5, 2	2013-02-05
Fusion Partner For Production Of Monoclonal Rabbit Antibodies App 20120238013 - Pytela; Robert ; et al.	2012-09-20
Fusion partner for production of monoclonal rabbit antibodies Grant 8,062,867 - Pytela , et al. November 22, 2	2011-11-22
Fusion Partner for Production of Monoclonal Rabbit Antibodies App 20110020934 - Pytela; Robert ; et al.	2011-01-27
Fusion partner for production of monoclonal rabbit antibodies Grant 7,732,168 - Pytela , et al. June 8, 2	2010-06-08
Methods of expressing integrin beta6 subunits App 20090253146 - Sheppard; Dean ; et al.	2009-10-08
Treatment of acute lung injury, fibrosis and metastasis with antagonists of .alpha.v.beta.6 Grant 7,544,358 - Huang , et al. June 9, 2	2009-06-09
Fusion Partner For Production Of Monoclonal Rabbit Antibodies App 20090142807 - PYTELA; ROBERT ; et al.	2009-06-04
Fusion partner for production of monoclonal rabbit antibodies Grant 7,429,487 - Pytela , et al. September 30, 2	2008-09-30
Methods of expressing integrin .beta..sub.6 subunits Grant 7,291,475 - Sheppard , et al. November 6, 2	2007-11-06
Treatment of Acute Lung Injury, Fibrosis and Metastasis with Antagonists of Alpha V Beta 6 App 20070148173 - Huang; Xiaozhu ; et al.	2007-06-28
Fusion partner for production of monoclonal rabbit antibodies App 20070015259 - Pytela; Robert ; et al.	2007-01-18
Methods of expressing integrin beta6 subunits App 20050129692 - Sheppard, Dean ; et al.	2005-06-16
Methods of expressing integrin .beta.6 subunits Grant 6,787,322 - Sheppard , et al. September 7, 2	2004-09-07
Multiplex system for production and screening of monoclonal antibodies App 20040111757 - Zhang, Dongxiao ; et al.	2004-06-10
Humanized rabbit antibodies App 20040086979 - Zhang, Dongxiao ; et al.	2004-05-06
System for production and screening of monoclonal antibodies App 20040067496 - Pytela, Robert ; et al.	2004-04-08
Antibodies specifically reactive with integrin .beta.6 subunits Grant 6,639,056 - Sheppard , et al. October 28, 2	2003-10-28
Methods of expressing integrin beta6 subunits App 20030064471 - Sheppard, Dean ; et al.	2003-04-03
Antibodies specifically reactive with integrin beta6 subunits App 20020164708 - Sheppard, Dean ; et al.	2002-11-07
Treatment Of Acute Lung Injury And Fibrosis With Antagonists Of Avbeta6 App 20020004482 - HUANG, XIAOZHU ; et al.	2002-01-10
Integrin .beta. subunit and uses thereof Grant 5,962,643 - Sheppard , et al. October 5, 1	1999-10-05

Company Registrations

NCAGE Code	46MT0	PYTELA ROBERT
CAGE Code	46MT0	PYTELA, ROBERT
DUNS	608536525	PYTELA, ROBERT

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.